Atlas Trials

Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy

Clinical trial NCT01484860 · TERMINATED

Trial details

NCT number
NCT01484860
Sponsor
University Health Network, Toronto
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Adenocarcinoma of the PancreasMetastatic Disease
Start date
2012-01-01
Primary completion
2013-08-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.